Tyra Biosciences appoints Bhavesh Ashar as COO; Bensen becomes Chief Discovery Officer

Tyra Biosciences, Inc.

Bhavesh Ashar appointed COO effective Dec 1, 2025; Daniel Bensen moved to Chief Discovery Officer.
Ashar base salary $550,000; target annual incentive 40% of base.
Granted options to purchase 300,000 shares vesting over 4 years (25% cliff at 1 year).
Severance provisions: 12 months salary plus target bonus if terminated without cause outside change in control.
Ashar previously Chief Commercial Officer at SpringWorks Therapeutics (Merck KGaA).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.